Results 21 to 30 of about 377,718 (262)
Frontiers in Endocrinology, 2021 IntroductionPheochromocytoma is a catecholamine-producing tumor in the adrenal medulla and is often accompanied by hypertension, hyperglycemia, hypermetabolism, headache, and hyperhidrosis, and it is classified as benign and malignant pheochromocytoma ...
Hideaki Kaneto +9 more
doaj +1 more source
Malignant Hypertension: Ocular Manifestations
The Scientific World Journal, 2006 Malignant hypertension may be the first manifestation of systemic hypertension. We report a clinical case of a Caucasian 41-year-old man with no previous history of blood hypertension seen at casualty because of blurred vision.
Silvia Muñoz +2 more
doaj +1 more source
Malignant hypertension secondary to renin-producing hepatoblastoma
Indian Journal of Medical and Paediatric Oncology, 2020 Clinical presentation of hepatoblastoma is often insidious and its paraneoplastic manifestations are not uncommon. We report an extremely rare case of a renin-secreting hepatoblastoma inducing malignant hypertension remarked in our clinic.
Doinita Sfrijan +3 more
doaj +1 more source
The fundus in malignant hypertension [PDF]
Nephrology Dialysis Transplantation, 1997 walls. Malignant hypertension is characterized by a tions following the course of the nerve fibres of the rapid downhill course. After 1 year 90% of untreated optic nerve. In advanced cases there is oedema of the patients are dead. Fibrinoid necrosis of arterioles is optic disc ( papilloedema). Moreover, choroidal lesions most prominent in the vascular
G, Gallasch, E, Ritz
openaire +2 more sources
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study
BMC Nephrology, 2012 Background Malignant hypertension is frequently complicated by renal insufficiency. Although the survival of this hypertensive emergency has improved, recent data on renal outcome and its predictors are lacking.
Amraoui Fouad +3 more
doaj +1 more source
The effects of acute administration of losartan, angiotensin II type-1 receptor antagonist, on hemodynamics and oxidative stress parameters in malignant hypertensive rats [PDF]
Veterinarski Glasnik, 2015 Malignant hypertension is a severe form of hypertension which pathogenesis is not fully elucidated. The aim of our study was to investigate the role of Angiotensin II on hemodynamic and oxidative stress parameters in model of malignant ...
Bogunović Natalija +7 more
doaj +1 more source
Hypertension in malignancy-an underappreciated problem [PDF]
Oncotarget, 2018 Hypertension is one of the most common comorbidities in cancer patients with malignancy, in particular, in the elderly. On the other hand, hypertension is a long-term consequence of antineoplastic treatment, including both chemotherapy and targeted agents.
Jolanta Małyszko +4 more
openaire +2 more sources
MALIGNANT HYPERTENSION WITH PREDOMINANT KIDNEY DAMAGE
Российский кардиологический журнал, 2018 The article is on a clinical case of malignant arterial hypertension in predominant kidney damage in a young man with disease anamnesis lasting 17 years.
N. D. Lapochkina +5 more
doaj +1 more source
Case Reports in Ophthalmological Medicine, 2011 Background. Idiopathic intracranial hypertension can cause rapid deterioration of visual acuity in some severe cases, and these cases are usually thought to have “malignant” form of this disease. Case.
Levent Sinan Bir +4 more
doaj +1 more source
BMC Veterinary Research, 2018 Background Malignant fibrous histiocytoma has been uncommonly described in dogs. Several extranasal neoplasias have been reported to result hypertensive epistaxis. There are, however, no published case reports of extranasal malignant fibrous histiocytoma
Jung-Hyun Kim +3 more
doaj +1 more source